/
/
Colgate-Palmolive Insider Stock Sale Follows Strong Earnings and Dividend Announcement

Colgate-Palmolive Insider Stock Sale Follows Strong Earnings and Dividend Announcement

Colgate-Palmolive Company, a major global consumer products business, recently saw insider Sally Massey sell over 15,800 shares of the company’s stock. The transaction, valued at more than $1.5 million, took place on February 5th and marked a 53.55% reduction in Massey’s stake, although she remains a shareholder with over 13,700 shares. The sale was officially reported to the Securities & Exchange Commission.

Following the insider sale, Colgate-Palmolive’s stock experienced a small drop, closing at $94.18 after falling $0.23. Trading volume reached more than 5.3 million shares, which is less than its normal average. The company’s market capitalization stands at $75.92 billion, with a price-to-earnings ratio of nearly 36. Colgate-Palmolive’s financial performance has remained solid, as demonstrated by its recent earnings report. In its quarterly report announced on January 30th, the company’s earnings per share (EPS) hit $0.95, exceeding analyst expectations. Revenue for the quarter was $5.23 billion, which represented a year-over-year increase of almost 6%.

Colgate-Palmolive has announced a quarterly dividend set for February 13th, offering $0.52 per share. This equates to an annual dividend of $2.08 and a dividend yield of 2.2%. The company’s payout ratio is currently at 79.39%. Institutional investors continue to show confidence in Colgate-Palmolive, with major firms increasing their positions in recent months. Notably, Allstate Corp and Harbour Investments Inc. both added significantly to their holdings, as did several other investment groups, leading to institutional ownership of over 80% of Colgate-Palmolive’s stock.

Equities analysts remain upbeat about Colgate-Palmolive’s prospects. Several investment banks, including JPMorgan Chase & Co., Citigroup, and Bank of America, either raised their price targets or reiterated buy recommendations for the stock. The consensus across analyst reports is in favor of a moderate buy, with an average target price currently near $94.47.

Colgate-Palmolive, which has roots going back to the early 19th century, manufactures and sells a wide range of household and personal care products. Its offerings include oral care products like toothpaste and mouthwash, personal care items such as soaps and deodorants, home cleaning solutions, and pet nutrition products. With steady financial performance, continued dividend payments, and strong institutional support, Colgate-Palmolive remains a key player in the consumer products sector.

Read More

WhatsApp